NCT03604016View on ClinicalTrials.gov

Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver

PHASE4UnknownINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

September 23, 2018

Primary Completion Date

July 30, 2020

Study Completion Date

July 30, 2020

Conditions
Hepatitis B
Interventions
DRUG

Besifovir dipivoxil

Besifovir dipivoxil 150 mg

DRUG

L-carnitine

Besifovir dipivoxil 150 mg

DRUG

Tenofovir Alafenamide

Tenofovir Alafenamide 25mg

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT03604016 - Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver | Biotech Hunter | Biotech Hunter